Global Antihemophilic Factor & von Willebrand Factor Complex Market Research Report 2023
Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A.
According to QYResearch’s new survey, global Antihemophilic Factor & von Willebrand Factor Complex market is projected to reach US$ 70 million in 2029, increasing from US$ 51 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antihemophilic Factor & von Willebrand Factor Complex market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antihemophilic Factor & von Willebrand Factor Complex market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Antihemophilic Factor & von Willebrand Factor Complex market is projected to reach US$ 70 million in 2029, increasing from US$ 51 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antihemophilic Factor & von Willebrand Factor Complex market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antihemophilic Factor & von Willebrand Factor Complex market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- CSL Behring
- Grifols
- Octapharma
- Takeda
- 5 ml
- 10 ml
- 15 ml
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 5 ml
1.2.3 10 ml
1.2.4 15 ml
1.3 Market by Application
1.3.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Perspective (2018-2029)
2.2 Antihemophilic Factor & von Willebrand Factor Complex Growth Trends by Region
2.2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Region (2018-2023)
2.2.3 Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Region (2024-2029)
2.3 Antihemophilic Factor & von Willebrand Factor Complex Market Dynamics
2.3.1 Antihemophilic Factor & von Willebrand Factor Complex Industry Trends
2.3.2 Antihemophilic Factor & von Willebrand Factor Complex Market Drivers
2.3.3 Antihemophilic Factor & von Willebrand Factor Complex Market Challenges
2.3.4 Antihemophilic Factor & von Willebrand Factor Complex Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Revenue
3.1.1 Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Revenue (2018-2023)
3.1.2 Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Players (2018-2023)
3.2 Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antihemophilic Factor & von Willebrand Factor Complex Revenue
3.4 Global Antihemophilic Factor & von Willebrand Factor Complex Market Concentration Ratio
3.4.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihemophilic Factor & von Willebrand Factor Complex Revenue in 2022
3.5 Antihemophilic Factor & von Willebrand Factor Complex Key Players Head office and Area Served
3.6 Key Players Antihemophilic Factor & von Willebrand Factor Complex Product Solution and Service
3.7 Date of Enter into Antihemophilic Factor & von Willebrand Factor Complex Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ANTIHEMOPHILIC FACTOR & VON WILLEBRAND FACTOR COMPLEX BREAKDOWN DATA BY TYPE
4.1 Global Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Type (2018-2023)
4.2 Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Type (2024-2029)
5 ANTIHEMOPHILIC FACTOR & VON WILLEBRAND FACTOR COMPLEX BREAKDOWN DATA BY APPLICATION
5.1 Global Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Application (2018-2023)
5.2 Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
6.2 North America Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
6.4 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
7.2 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
7.4 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
8.2 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2018-2023)
8.4 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
9.2 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
9.4 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
10.2 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
10.4 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 CSL Behring
11.1.1 CSL Behring Company Detail
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.1.4 CSL Behring Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Detail
11.2.2 Grifols Business Overview
11.2.3 Grifols Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.2.4 Grifols Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.2.5 Grifols Recent Development
11.3 Octapharma
11.3.1 Octapharma Company Detail
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.3.4 Octapharma Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.3.5 Octapharma Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.4.4 Takeda Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.4.5 Takeda Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 5 ml
1.2.3 10 ml
1.2.4 15 ml
1.3 Market by Application
1.3.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Perspective (2018-2029)
2.2 Antihemophilic Factor & von Willebrand Factor Complex Growth Trends by Region
2.2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Region (2018-2023)
2.2.3 Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Region (2024-2029)
2.3 Antihemophilic Factor & von Willebrand Factor Complex Market Dynamics
2.3.1 Antihemophilic Factor & von Willebrand Factor Complex Industry Trends
2.3.2 Antihemophilic Factor & von Willebrand Factor Complex Market Drivers
2.3.3 Antihemophilic Factor & von Willebrand Factor Complex Market Challenges
2.3.4 Antihemophilic Factor & von Willebrand Factor Complex Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Revenue
3.1.1 Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Revenue (2018-2023)
3.1.2 Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Players (2018-2023)
3.2 Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antihemophilic Factor & von Willebrand Factor Complex Revenue
3.4 Global Antihemophilic Factor & von Willebrand Factor Complex Market Concentration Ratio
3.4.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihemophilic Factor & von Willebrand Factor Complex Revenue in 2022
3.5 Antihemophilic Factor & von Willebrand Factor Complex Key Players Head office and Area Served
3.6 Key Players Antihemophilic Factor & von Willebrand Factor Complex Product Solution and Service
3.7 Date of Enter into Antihemophilic Factor & von Willebrand Factor Complex Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ANTIHEMOPHILIC FACTOR & VON WILLEBRAND FACTOR COMPLEX BREAKDOWN DATA BY TYPE
4.1 Global Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Type (2018-2023)
4.2 Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Type (2024-2029)
5 ANTIHEMOPHILIC FACTOR & VON WILLEBRAND FACTOR COMPLEX BREAKDOWN DATA BY APPLICATION
5.1 Global Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Application (2018-2023)
5.2 Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
6.2 North America Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
6.4 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
7.2 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
7.4 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
8.2 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2018-2023)
8.4 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
9.2 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
9.4 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size (2018-2029)
10.2 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023)
10.4 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 CSL Behring
11.1.1 CSL Behring Company Detail
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.1.4 CSL Behring Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Detail
11.2.2 Grifols Business Overview
11.2.3 Grifols Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.2.4 Grifols Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.2.5 Grifols Recent Development
11.3 Octapharma
11.3.1 Octapharma Company Detail
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.3.4 Octapharma Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.3.5 Octapharma Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.4.4 Takeda Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
11.4.5 Takeda Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of 5 ml
Table 3. Key Players of 10 ml
Table 4. Key Players of 15 ml
Table 5. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2018-2023)
Table 9. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2024-2029)
Table 11. Antihemophilic Factor & von Willebrand Factor Complex Market Trends
Table 12. Antihemophilic Factor & von Willebrand Factor Complex Market Drivers
Table 13. Antihemophilic Factor & von Willebrand Factor Complex Market Challenges
Table 14. Antihemophilic Factor & von Willebrand Factor Complex Market Restraints
Table 15. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Players (2018-2023)
Table 17. Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihemophilic Factor & von Willebrand Factor Complex as of 2022)
Table 18. Ranking of Global Top Antihemophilic Factor & von Willebrand Factor Complex Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Antihemophilic Factor & von Willebrand Factor Complex Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antihemophilic Factor & von Willebrand Factor Complex Product Solution and Service
Table 22. Date of Enter into Antihemophilic Factor & von Willebrand Factor Complex Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2018-2023)
Table 26. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2024-2029)
Table 28. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Application (2018-2023)
Table 30. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Application (2024-2029)
Table 32. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 47. CSL Behring Company Detail
Table 48. CSL Behring Business Overview
Table 49. CSL Behring Antihemophilic Factor & von Willebrand Factor Complex Product
Table 50. CSL Behring Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 51. CSL Behring Recent Development
Table 52. Grifols Company Detail
Table 53. Grifols Business Overview
Table 54. Grifols Antihemophilic Factor & von Willebrand Factor Complex Product
Table 55. Grifols Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 56. Grifols Recent Development
Table 57. Octapharma Company Detail
Table 58. Octapharma Business Overview
Table 59. Octapharma Antihemophilic Factor & von Willebrand Factor Complex Product
Table 60. Octapharma Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 61. Octapharma Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Antihemophilic Factor & von Willebrand Factor Complex Product
Table 65. Takeda Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 1. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of 5 ml
Table 3. Key Players of 10 ml
Table 4. Key Players of 15 ml
Table 5. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2018-2023)
Table 9. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2024-2029)
Table 11. Antihemophilic Factor & von Willebrand Factor Complex Market Trends
Table 12. Antihemophilic Factor & von Willebrand Factor Complex Market Drivers
Table 13. Antihemophilic Factor & von Willebrand Factor Complex Market Challenges
Table 14. Antihemophilic Factor & von Willebrand Factor Complex Market Restraints
Table 15. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Players (2018-2023)
Table 17. Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihemophilic Factor & von Willebrand Factor Complex as of 2022)
Table 18. Ranking of Global Top Antihemophilic Factor & von Willebrand Factor Complex Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Antihemophilic Factor & von Willebrand Factor Complex Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antihemophilic Factor & von Willebrand Factor Complex Product Solution and Service
Table 22. Date of Enter into Antihemophilic Factor & von Willebrand Factor Complex Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2018-2023)
Table 26. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2024-2029)
Table 28. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Application (2018-2023)
Table 30. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Application (2024-2029)
Table 32. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2024-2029) & (US$ Million)
Table 47. CSL Behring Company Detail
Table 48. CSL Behring Business Overview
Table 49. CSL Behring Antihemophilic Factor & von Willebrand Factor Complex Product
Table 50. CSL Behring Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 51. CSL Behring Recent Development
Table 52. Grifols Company Detail
Table 53. Grifols Business Overview
Table 54. Grifols Antihemophilic Factor & von Willebrand Factor Complex Product
Table 55. Grifols Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 56. Grifols Recent Development
Table 57. Octapharma Company Detail
Table 58. Octapharma Business Overview
Table 59. Octapharma Antihemophilic Factor & von Willebrand Factor Complex Product
Table 60. Octapharma Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 61. Octapharma Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Antihemophilic Factor & von Willebrand Factor Complex Product
Table 65. Takeda Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type: 2022 VS 2029
Figure 3. 5 ml Features
Figure 4. 10 ml Features
Figure 5. 15 ml Features
Figure 6. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Antihemophilic Factor & von Willebrand Factor Complex Report Years Considered
Figure 11. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region: 2022 VS 2029
Figure 14. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Players in 2022
Figure 15. Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihemophilic Factor & von Willebrand Factor Complex as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Antihemophilic Factor & von Willebrand Factor Complex Revenue in 2022
Figure 17. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 19. United States Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 23. Germany Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2018-2029)
Figure 31. China Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 39. Mexico Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 43. Turkey Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. CSL Behring Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 46. Grifols Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 47. Octapharma Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 48. Takeda Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Figure 1. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type: 2022 VS 2029
Figure 3. 5 ml Features
Figure 4. 10 ml Features
Figure 5. 15 ml Features
Figure 6. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Antihemophilic Factor & von Willebrand Factor Complex Report Years Considered
Figure 11. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region: 2022 VS 2029
Figure 14. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Players in 2022
Figure 15. Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihemophilic Factor & von Willebrand Factor Complex as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Antihemophilic Factor & von Willebrand Factor Complex Revenue in 2022
Figure 17. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 19. United States Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 23. Germany Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2018-2029)
Figure 31. China Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 39. Mexico Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2018-2029)
Figure 43. Turkey Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. CSL Behring Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 46. Grifols Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 47. Octapharma Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 48. Takeda Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
